Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease
Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative disorder with a high prevalence. Since behavioral disturbances, such as psychotic symptoms, represent a key feature of AD, genes related to dopamine, serotonin and brain derived neurotrophic factor (BDNF), are considered...
Saved in:
| Published in: | Progress in neuro-psychopharmacology & biological psychiatry Vol. 35; no. 2; pp. 356 - 362 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Elsevier Inc
30-03-2011
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative disorder with a high prevalence. Since behavioral disturbances, such as psychotic symptoms, represent a key feature of AD, genes related to dopamine, serotonin and brain derived neurotrophic factor (BDNF), are considered as candidate genes for AD. BDNF is a neurotrophin that regulates neurodevelopment, neuroplasticity, and neuronal functions. BDNF is involved in the etiopathogenesis of psychiatric and neurodegenerative disorders. A single base pair polymorphism (BDNF Val66Met) was reported to be associated with AD and/or schizophrenia, as well as other psychoses, although some studies failed to replicate these findings. The aim of the study was to evaluate the association between BDNF Val66Met variants and AD, as well as onset of AD or presence of psychotic symptoms in AD.
BDNF Val66Met was analyzed in 211 patients with AD and in 402 aged healthy control subjects. All subjects were ethnically homogenous Caucasians from Croatia, and were subdivided according to the gender, onset of AD, and presence of psychotic symptoms. A χ2 test, with Bonferroni correction and standardized residuals were used to evaluate the data.
Distribution of the BDNF Val66Met genotypes differed significantly between male and female AD patients with or without psychotic symptoms. This difference was due to the significant contribution of the Met/Val genotype and the combined Met/Met and Met/Val genotypes between psychotic and non-psychotic symptoms in male, but not in female patients with AD. The frequency of the gene variants of the BDNF Val66Met did not differ significantly among male and female patients with AD and control subjects, or between male and female patients with early or late onset AD. There were significant sex related differences in age, duration of illness and scores of dementia between patients with AD.
Our male patients were younger, had shorter duration of illness, and had less severe dementia and higher cognitive performance than female AD patients. The gene variants of the BDNF Val66Met polymorphism were significantly associated with the presence of psychotic symptoms in male, but not in female patients with AD. The results had adequate statistical power to suggest that BDNF Val66Met was not related to susceptibility to AD or the onset of AD, but that presence of one or two Met alleles of BDNF Val66Met polymorphism might present a risk factor for psychosis in AD.
► First significant association between BDNF Val66Met variants and psychotic AD. ► Significant difference between male psychotic and non-psychotic patients. ► This difference was induced by a major contribution of the BDNF Met genotypes. ► Carrying one or two Met alleles of BDNF is a risk factor for psychosis in AD. |
|---|---|
| AbstractList | OBJECTIVEAlzheimer's disease (AD) is an irreversible, progressive neurodegenerative disorder with a high prevalence. Since behavioral disturbances, such as psychotic symptoms, represent a key feature of AD, genes related to dopamine, serotonin and brain derived neurotrophic factor (BDNF), are considered as candidate genes for AD. BDNF is a neurotrophin that regulates neurodevelopment, neuroplasticity, and neuronal functions. BDNF is involved in the etiopathogenesis of psychiatric and neurodegenerative disorders. A single base pair polymorphism (BDNF Val66Met) was reported to be associated with AD and/or schizophrenia, as well as other psychoses, although some studies failed to replicate these findings. The aim of the study was to evaluate the association between BDNF Val66Met variants and AD, as well as onset of AD or presence of psychotic symptoms in AD.METHODBDNF Val66Met was analyzed in 211 patients with AD and in 402 aged healthy control subjects. All subjects were ethnically homogenous Caucasians from Croatia, and were subdivided according to the gender, onset of AD, and presence of psychotic symptoms. A χ(2) test, with Bonferroni correction and standardized residuals were used to evaluate the data.RESULTSDistribution of the BDNF Val66Met genotypes differed significantly between male and female AD patients with or without psychotic symptoms. This difference was due to the significant contribution of the Met/Val genotype and the combined Met/Met and Met/Val genotypes between psychotic and non-psychotic symptoms in male, but not in female patients with AD. The frequency of the gene variants of the BDNF Val66Met did not differ significantly among male and female patients with AD and control subjects, or between male and female patients with early or late onset AD. There were significant sex related differences in age, duration of illness and scores of dementia between patients with AD.CONCLUSIONOur male patients were younger, had shorter duration of illness, and had less severe dementia and higher cognitive performance than female AD patients. The gene variants of the BDNF Val66Met polymorphism were significantly associated with the presence of psychotic symptoms in male, but not in female patients with AD. The results had adequate statistical power to suggest that BDNF Val66Met was not related to susceptibility to AD or the onset of AD, but that presence of one or two Met alleles of BDNF Val66Met polymorphism might present a risk factor for psychosis in AD. Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative disorder with a high prevalence. Since behavioral disturbances, such as psychotic symptoms, represent a key feature of AD, genes related to dopamine, serotonin and brain derived neurotrophic factor (BDNF), are considered as candidate genes for AD. BDNF is a neurotrophin that regulates neurodevelopment, neuroplasticity, and neuronal functions. BDNF is involved in the etiopathogenesis of psychiatric and neurodegenerative disorders. A single base pair polymorphism (BDNF Val66Met) was reported to be associated with AD and/or schizophrenia, as well as other psychoses, although some studies failed to replicate these findings. The aim of the study was to evaluate the association between BDNF Val66Met variants and AD, as well as onset of AD or presence of psychotic symptoms in AD. Method: BDNF Val66Met was analyzed in 211 patients with AD and in 402 aged healthy control subjects. All subjects were ethnically homogenous Caucasians from Croatia, and were subdivided according to the gender, onset of AD, and presence of psychotic symptoms. A [chi][super]2 test, with Bonferroni correction and standardized residuals were used to evaluate the data. Results: Distribution of the BDNF Val66Met genotypes differed significantly between male and female AD patients with or without psychotic symptoms. This difference was due to the significant contribution of the Met/Val genotype and the combined Met/Met and Met/Val genotypes between psychotic and non-psychotic symptoms in male, but not in female patients with AD. The frequency of the gene variants of the BDNF Val66Met did not differ significantly among male and female patients with AD and control subjects, or between male and female patients with early or late onset AD. There were significant sex related differences in age, duration of illness and scores of dementia between patients with AD. Conclusion: Our male patients were younger, had shorter duration of illness, and had less severe dementia and higher cognitive performance than female AD patients. The gene variants of the BDNF Val66Met polymorphism were significantly associated with the presence of psychotic symptoms in male, but not in female patients with AD. The results had adequate statistical power to suggest that BDNF Val66Met was not related to susceptibility to AD or the onset of AD, but that presence of one or two Met alleles of BDNF Val66Met polymorphism might present a risk factor for psychosis in AD. Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative disorder with a high prevalence. Since behavioral disturbances, such as psychotic symptoms, represent a key feature of AD, genes related to dopamine, serotonin and brain derived neurotrophic factor (BDNF), are considered as candidate genes for AD. BDNF is a neurotrophin that regulates neurodevelopment, neuroplasticity, and neuronal functions. BDNF is involved in the etiopathogenesis of psychiatric and neurodegenerative disorders. A single base pair polymorphism (BDNF Val66Met) was reported to be associated with AD and/or schizophrenia, as well as other psychoses, although some studies failed to replicate these findings. The aim of the study was to evaluate the association between BDNF Val66Met variants and AD, as well as onset of AD or presence of psychotic symptoms in AD. BDNF Val66Met was analyzed in 211 patients with AD and in 402 aged healthy control subjects. All subjects were ethnically homogenous Caucasians from Croatia, and were subdivided according to the gender, onset of AD, and presence of psychotic symptoms. A χ(2) test, with Bonferroni correction and standardized residuals were used to evaluate the data. Distribution of the BDNF Val66Met genotypes differed significantly between male and female AD patients with or without psychotic symptoms. This difference was due to the significant contribution of the Met/Val genotype and the combined Met/Met and Met/Val genotypes between psychotic and non-psychotic symptoms in male, but not in female patients with AD. The frequency of the gene variants of the BDNF Val66Met did not differ significantly among male and female patients with AD and control subjects, or between male and female patients with early or late onset AD. There were significant sex related differences in age, duration of illness and scores of dementia between patients with AD. Our male patients were younger, had shorter duration of illness, and had less severe dementia and higher cognitive performance than female AD patients. The gene variants of the BDNF Val66Met polymorphism were significantly associated with the presence of psychotic symptoms in male, but not in female patients with AD. The results had adequate statistical power to suggest that BDNF Val66Met was not related to susceptibility to AD or the onset of AD, but that presence of one or two Met alleles of BDNF Val66Met polymorphism might present a risk factor for psychosis in AD. Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative disorder with a high prevalence. Since behavioral disturbances, such as psychotic symptoms, represent a key feature of AD, genes related to dopamine, serotonin and brain derived neurotrophic factor (BDNF), are considered as candidate genes for AD. BDNF is a neurotrophin that regulates neurodevelopment, neuroplasticity, and neuronal functions. BDNF is involved in the etiopathogenesis of psychiatric and neurodegenerative disorders. A single base pair polymorphism (BDNF Val66Met) was reported to be associated with AD and/or schizophrenia, as well as other psychoses, although some studies failed to replicate these findings. The aim of the study was to evaluate the association between BDNF Val66Met variants and AD, as well as onset of AD or presence of psychotic symptoms in AD. BDNF Val66Met was analyzed in 211 patients with AD and in 402 aged healthy control subjects. All subjects were ethnically homogenous Caucasians from Croatia, and were subdivided according to the gender, onset of AD, and presence of psychotic symptoms. A χ2 test, with Bonferroni correction and standardized residuals were used to evaluate the data. Distribution of the BDNF Val66Met genotypes differed significantly between male and female AD patients with or without psychotic symptoms. This difference was due to the significant contribution of the Met/Val genotype and the combined Met/Met and Met/Val genotypes between psychotic and non-psychotic symptoms in male, but not in female patients with AD. The frequency of the gene variants of the BDNF Val66Met did not differ significantly among male and female patients with AD and control subjects, or between male and female patients with early or late onset AD. There were significant sex related differences in age, duration of illness and scores of dementia between patients with AD. Our male patients were younger, had shorter duration of illness, and had less severe dementia and higher cognitive performance than female AD patients. The gene variants of the BDNF Val66Met polymorphism were significantly associated with the presence of psychotic symptoms in male, but not in female patients with AD. The results had adequate statistical power to suggest that BDNF Val66Met was not related to susceptibility to AD or the onset of AD, but that presence of one or two Met alleles of BDNF Val66Met polymorphism might present a risk factor for psychosis in AD. ► First significant association between BDNF Val66Met variants and psychotic AD. ► Significant difference between male psychotic and non-psychotic patients. ► This difference was induced by a major contribution of the BDNF Met genotypes. ► Carrying one or two Met alleles of BDNF is a risk factor for psychosis in AD. |
| Author | Pivac, Nela Hajnsek, Sanja Pavlovic, Mladen Mimica, Ninoslav Nikolac, Matea Borovecki, Fran Mustapic, Maja Muck Seler, Dorotea Presecki, Paola Nedic, Gordana |
| Author_xml | – sequence: 1 givenname: Nela surname: Pivac fullname: Pivac, Nela email: npivac@irb.hr organization: Division of Molecular Medicine, Rudjer Boskovic Institute, Croatia – sequence: 2 givenname: Matea surname: Nikolac fullname: Nikolac, Matea organization: Division of Molecular Medicine, Rudjer Boskovic Institute, Croatia – sequence: 3 givenname: Gordana surname: Nedic fullname: Nedic, Gordana organization: Division of Molecular Medicine, Rudjer Boskovic Institute, Croatia – sequence: 4 givenname: Maja surname: Mustapic fullname: Mustapic, Maja organization: Division of Molecular Medicine, Rudjer Boskovic Institute, Croatia – sequence: 5 givenname: Fran surname: Borovecki fullname: Borovecki, Fran organization: Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia – sequence: 6 givenname: Sanja surname: Hajnsek fullname: Hajnsek, Sanja organization: Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia – sequence: 7 givenname: Paola surname: Presecki fullname: Presecki, Paola organization: Psychiatric Hospital “Sveti Ivan”, Zagreb, Croatia – sequence: 8 givenname: Mladen surname: Pavlovic fullname: Pavlovic, Mladen organization: Institute for Medical Research and Occupational Health, Zagreb, Croatia – sequence: 9 givenname: Ninoslav surname: Mimica fullname: Mimica, Ninoslav organization: Psychiatric Hospital Vrapce, Zagreb, Croatia – sequence: 10 givenname: Dorotea surname: Muck Seler fullname: Muck Seler, Dorotea organization: Division of Molecular Medicine, Rudjer Boskovic Institute, Croatia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21044653$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUFPGzEQhS1EBSHwC5Aq3zgleHZts3vogaIWkKh6KVwtrz1WHO2uXXuDFH49DoEeiy-2nr95I713Qg7HMCIh58CWwEBerpdxjF1cVuxNWbKKHZAZNFfNglcgD8mMVeUtGi6PyUnOa8YY1Kw-IscVMM6lqGcEvyftR2ox-We0dMRNClMKceUNddpMIdEn3Uv5CycaQ78dQip_eaB6tDTmrVmFqaB5O8QpDJkWr-v-ZYV-wHSRqfUZdcZT8sXpPuPZ-z0njz9__Lm5Wzz8vr2_uX5YmPoKpkXbsdYJ6KxFDrJqGs6tcLZ1BjrZ6M4WQYBzElvBeeUqEBwagUY41oK09Zxc7H1jCn83mCc1-Gyw7_WIYZNVI0siAoB9ToqWCV6XMyf1njQp5JzQqZj8oNNWAVO7ItRavRWhdkXsxFJEmfr67r_pBrT_Zj6SL8C3PYAlj2ePSWXjcTRofUIzKRv8fxe8AtYHnSs |
| CitedBy_id | crossref_primary_10_1016_j_pnpbp_2011_08_003 crossref_primary_10_1093_gerona_glx092 crossref_primary_10_3109_00207454_2012_762515 crossref_primary_10_1016_j_neurobiolaging_2016_12_023 crossref_primary_10_1159_000353269 crossref_primary_10_1016_j_neulet_2013_04_036 crossref_primary_10_3109_00207454_2013_869594 crossref_primary_10_1016_j_lfs_2020_118020 crossref_primary_10_1007_s10548_011_0196_8 crossref_primary_10_3389_fpsyt_2023_1234220 crossref_primary_10_1007_s00213_014_3515_4 crossref_primary_10_1016_j_pnpbp_2012_09_005 crossref_primary_10_3109_15622975_2011_582883 crossref_primary_10_1016_j_exger_2011_04_001 crossref_primary_10_1016_j_mehy_2019_02_001 crossref_primary_10_1111_j_1365_2826_2012_02365_x crossref_primary_10_1016_j_gene_2019_05_030 crossref_primary_10_3892_etm_2015_2327 crossref_primary_10_3390_ijms22126619 crossref_primary_10_1177_1533317517733037 crossref_primary_10_1007_s12041_014_0449_x crossref_primary_10_3233_JAD_221247 crossref_primary_10_1002_ajmg_b_32183 crossref_primary_10_1016_j_cytogfr_2012_01_002 crossref_primary_10_9758_cpn_2012_10_2_61 crossref_primary_10_3390_jpm13040658 crossref_primary_10_3390_cells9051194 crossref_primary_10_1186_1423_0127_20_57 |
| Cites_doi | 10.1016/j.neulet.2004.06.039 10.1016/j.pnpbp.2010.04.019 10.1016/j.brainresrev.2008.07.007 10.1016/j.neulet.2006.02.054 10.1007/s00702-004-0210-3 10.1016/j.neulet.2005.04.104 10.1038/mp.2008.109 10.1523/JNEUROSCI.0348-04.2004 10.1523/JNEUROSCI.2680-04.2004 10.1002/ajmg.b.30986 10.1038/sj.tpj.6500337 10.1097/00019442-200002000-00004 10.1016/j.tics.2004.05.011 10.1212/WNL.54.10.1965 10.1016/S0024-3205(01)01461-8 10.1016/j.neulet.2005.01.008 10.1007/s00439-002-0819-y 10.1056/NEJMra040223 10.3233/JAD-2009-1191 10.1016/0022-3956(75)90026-6 10.1016/j.jpsychires.2008.05.008 10.1002/ajmg.b.30332 10.1146/annurev.neuro.24.1.677 10.1016/j.expneurol.2005.01.026 10.1159/000106473 10.1038/sj.npp.1301148 10.1038/sj.mp.4001702 10.1111/j.1601-183X.2008.00434.x 10.1159/000075332 10.1212/WNL.44.12.2308 10.1016/j.neures.2006.04.006 10.1056/NEJMcp022295 10.1016/j.pharmthera.2007.06.006 10.1016/j.biopsych.2006.08.025 10.1212/WNL.46.1.130 10.1093/nar/16.3.1215 10.1053/scnp.2003.50014 10.1523/JNEUROSCI.23-17-06690.2003 10.1016/j.neulet.2005.07.009 10.1016/S0092-8674(03)00035-7 10.1016/j.neurobiolaging.2007.02.024 10.1016/j.pnpbp.2006.02.008 10.1002/ajmg.b.30266 10.1016/j.biopsych.2005.09.022 10.1001/archneur.57.6.846 10.1016/j.jpsychires.2006.01.014 10.1016/S0022-3956(03)00092-X 10.1017/S1461145709991015 10.3325/cmj.2009.50.43 10.1196/annals.1386.008 10.1016/j.neurobiolaging.2005.09.029 10.1038/sj.mp.4000952 10.1159/000090673 10.1111/j.1468-1331.2006.01165.x 10.1212/WNL.34.7.939 10.3233/JAD-2007-12108 10.2174/156720510790691173 10.1007/s11064-005-8827-7 10.1007/s00406-006-0652-8 10.1007/s00415-005-0667-5 |
| ContentType | Journal Article |
| Copyright | 2010 Elsevier Inc. Copyright © 2010 Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2010 Elsevier Inc. – notice: Copyright © 2010 Elsevier Inc. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7TK |
| DOI | 10.1016/j.pnpbp.2010.10.020 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Neurosciences Abstracts |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic Neurosciences Abstracts |
| DatabaseTitleList | MEDLINE - Academic Neurosciences Abstracts MEDLINE |
| Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1878-4216 |
| EndPage | 362 |
| ExternalDocumentID | 10_1016_j_pnpbp_2010_10_020 21044653 S0278584610004069 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Croatia |
| GeographicLocations_xml | – name: Croatia |
| GroupedDBID | --- --K --M .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AADPK AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AATCM AAXLA AAXUO ABCQJ ABFRF ABIVO ABJNI ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGWIK AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA HZ~ IHE J1W KOM L7B M2V M34 M41 MO0 MOBAO N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SES SSN SSP SSZ T5K TEORI ~G- AAXKI AKRWK CGR CUY CVF ECM EIF NPM .GJ 29P 53G AAQXK AAYXX AFJKZ AHHHB ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB G-2 HMQ HMT HVGLF R2- SEW SNS SPT WUQ ZGI 7X8 7TK |
| ID | FETCH-LOGICAL-c371t-9b09f51bdde41628844d5fd9fc1b68abd84451ff6e95442f2154185ec5f0916d3 |
| ISSN | 0278-5846 |
| IngestDate | Fri Oct 25 09:34:33 EDT 2024 Sat Oct 05 06:24:19 EDT 2024 Thu Sep 26 16:30:59 EDT 2024 Sat Sep 28 08:46:44 EDT 2024 Fri Feb 23 02:24:42 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Val Male and female subjects AD ANOVA BDNF Onset of disease MMSE Psychotic symptoms HWE Brain derived neurotrophic factor Val66Met Met Alzheimer's disease |
| Language | English |
| License | Copyright © 2010 Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c371t-9b09f51bdde41628844d5fd9fc1b68abd84451ff6e95442f2154185ec5f0916d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| PMID | 21044653 |
| PQID | 859054333 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_862785110 proquest_miscellaneous_859054333 crossref_primary_10_1016_j_pnpbp_2010_10_020 pubmed_primary_21044653 elsevier_sciencedirect_doi_10_1016_j_pnpbp_2010_10_020 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-03-30 |
| PublicationDateYYYYMMDD | 2011-03-30 |
| PublicationDate_xml | – month: 03 year: 2011 text: 2011-03-30 day: 30 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Progress in neuro-psychopharmacology & biological psychiatry |
| PublicationTitleAlternate | Prog Neuropsychopharmacol Biol Psychiatry |
| PublicationYear | 2011 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Bueller, Aftab, Sen, Gomez-Hassan, Burmeister, Zubieta (bb0030) 2006; 59 McKhann, Drachman, Folstein, Katzman, Price, Stadlan (bb0175) 1984; 34 Frey, Mattila, Korolainen, Pirttila (bb0085) 2005; 30 Tsai, Hong, Liu, Liu, Hsu, Lin (bb0260) 2004; 49 Pillai, Kale, Joshi, Naphade, Raju, Nasrallah (bb0215) 2010; 13 Fumagalli, Racagni, Riva (bb0095) 2006; 6 Tsai, Hong, Liu, Liu, Liou (bb0265) 2006; 21 Li, Rowland, Tacey, Catanese, Sninsky, Hardy (bb0165) 2005; 10 He, Zhang, Zhang, Zhou, Tang, Wu (bb0125) 2007; 55 Jeste, Finkel (bb0140) 2000; 8 Bian, Zhang, Zhang, Zhao (bb0010) 2005; 387 Findeis (bb0065) 2007; 116 Huang, Reichardt (bb0135) 2001; 24 Paulsen, Salmon, Thal, Romero, Weisstein-Jenkins, Galasko (bb0205) 2000; 54 Yasutake, Kuroda, Yanagawa, Okamura, Yoneda (bb0305) 2006; 256 Forero, Benitez, Arboleda, Yunis, Pardo, Arboleda (bb0075) 2006; 55 Miller, Dykes, Polesky (bb0185) 1988; 16 Rosa, Cuesta, Fatjo-Vilas, Peralta, Zarzuela, Fananas (bb0225) 2006; 141B Tapia-Arancibia, Aliaga, Silhol, Arancibia (bb0255) 2008; 59 Cummings, Mega, Gray, Rosenberg-Thompson, Carusi, Gornbein (bb0050) 1994; 44 Yamada, Mizuno, Nabeshima (bb0300) 2002; 70 Mega, Cummings, Fiorello, Gornbein (bb0180) 1996; 46 Pezawas, Verchinski, Mattay, Callicott, Kolachana, Straub (bb0210) 2004; 24 Egan, Kojima, Callicott, Goldberg, Kolachana, Bertolino (bb0060) 2003; 112 Russo-Neustadt (bb0230) 2003; 8 Verhagen, van der Meij, van Deurzen, Janzing, Arias-Vásquez, Buitelaar (bb0280) 2010; 15 Moran, Becker, Satlin, Lyoo, Fischman, Johnson (bb0190) 2008; 29 Simons, Wichers, Derom, Thiery, Myin-Germeys, Krabbendam (bb0245) 2009; 8 Lee, Fukumoto, Orne, Klucken, Raju, Vanderburg (bb0160) 2005; 194 Spalletta, Bernardini, Bellincampi, Federici, Trequattrini, Caltagirone (bb0250) 2006; 13 Jonsson, Edman-Ahlbom, Sillen, Gunnar, Kulle, Frigessi (bb0145) 2006; 30 Xu, Turner, Little, Bleecker, Meyers (bb0295) 2002; 111 Zhang, Ozbay, Lappalainen, Kranzler, van Dyck, Charney (bb0315) 2006; 141B Gratacos, Gonzalez, Mercader, de Cid, Urretavizcaya, Estivill (bb0105) 2007; 61 Schneider, Dagerman (bb0235) 2004; 38 Zdanys, Kleiman, MacAvoy, Black, Rightmer, Grey (bb0310) 2007; 32 Borroni, Costanzi, Padovani (bb0025) 2010; 7 Hariri, Goldberg, Mattay, Kolachana, Callicott, Egan (bb0115) 2003; 23 (bb0290) 1992 Desai, Nebes, DeKosky, Kamboh (bb0055) 2005; 379 Folstein, Folstein, McHugh (bb0070) 1975; 12 (bb0005) 1994 Candore, Balistreri, Grimaldi, Vasto, Listi, Chiappelli (bb0035) 2006; 1089 Zhou, Yan, Yan, Li, Fang, Zheng (bb0320) 2010; 34 Grunblatt, Zehetmayer, Bartl, Loffler, Wichart, Rainer (bb0110) 2009; 43 Wenk (bb0285) 2003; 64 Cummings (bb0045) 2004; 351 Pivac, Kim, Nedic, Joo, Kozaric-Kovacic, Hong (bb0220) 2009; 50 Ventriglia, Bocchio Chiavetto, Benussi, Binetti, Zanetti, Riva (bb0270) 2002; 7 Laske, Stransky, Leyhe, Eschweiler, Maetzler, Wittorf (bb0155) 2007; 41 Chen, Patel, Sant, Meng, Teng, Hempstead (bb0040) 2004; 24 Hock, Heese, Hulette, Rosenberg, Otten (bb0130) 2000; 57 Borroni, Grassi, Agosti, Costanzi, Archetti, Franzoni (bb0015) 2006; 27 Serretti, Olgiati, De Ronchi (bb0240) 2007; 12 Numata, Ueno, Iga, Yamauchi, Hongwei, Ohta (bb0200) 2006; 401 Fukumoto, Fujii, Combarros, Kamboh, Tsai, Matsushita (bb0090) 2010; 153B Fratiglioni, Launer, Andersen, Breteler, Copeland, Dartigues (bb0080) 2000; 54 Nacmias, Piccini, Bagnoli, Tedde, Cellini, Bracco (bb0195) 2004; 367 Harris, Wright, Hayward, Starr, Whalley, Deary (bb0120) 2005; 385 Matsushita, Arai, Matsui, Yuzuriha, Urakami, Masaki (bb0170) 2005; 112 Vepsalainen, Castren, Helisalmi, Iivonen, Mannermaa, Lehtovirta (bb0275) 2005; 252 Kawas (bb0150) 2003; 349 Borroni, Grassi, Archetti, Costanzi, Bianchi, Caimi (bb0020) 2009; 18 Goldberg, Weinberger (bb0100) 2004; 8 Goldberg (10.1016/j.pnpbp.2010.10.020_bb0100) 2004; 8 Folstein (10.1016/j.pnpbp.2010.10.020_bb0070) 1975; 12 Pivac (10.1016/j.pnpbp.2010.10.020_bb0220) 2009; 50 Hariri (10.1016/j.pnpbp.2010.10.020_bb0115) 2003; 23 Bueller (10.1016/j.pnpbp.2010.10.020_bb0030) 2006; 59 Forero (10.1016/j.pnpbp.2010.10.020_bb0075) 2006; 55 Verhagen (10.1016/j.pnpbp.2010.10.020_bb0280) 2010; 15 He (10.1016/j.pnpbp.2010.10.020_bb0125) 2007; 55 Cummings (10.1016/j.pnpbp.2010.10.020_bb0045) 2004; 351 Wenk (10.1016/j.pnpbp.2010.10.020_bb0285) 2003; 64 Zhou (10.1016/j.pnpbp.2010.10.020_bb0320) 2010; 34 Bian (10.1016/j.pnpbp.2010.10.020_bb0010) 2005; 387 Borroni (10.1016/j.pnpbp.2010.10.020_bb0025) 2010; 7 Zdanys (10.1016/j.pnpbp.2010.10.020_bb0310) 2007; 32 Simons (10.1016/j.pnpbp.2010.10.020_bb0245) 2009; 8 Fratiglioni (10.1016/j.pnpbp.2010.10.020_bb0080) 2000; 54 Desai (10.1016/j.pnpbp.2010.10.020_bb0055) 2005; 379 Gratacos (10.1016/j.pnpbp.2010.10.020_bb0105) 2007; 61 Schneider (10.1016/j.pnpbp.2010.10.020_bb0235) 2004; 38 Findeis (10.1016/j.pnpbp.2010.10.020_bb0065) 2007; 116 Mega (10.1016/j.pnpbp.2010.10.020_bb0180) 1996; 46 Pillai (10.1016/j.pnpbp.2010.10.020_bb0215) 2010; 13 Russo-Neustadt (10.1016/j.pnpbp.2010.10.020_bb0230) 2003; 8 Grunblatt (10.1016/j.pnpbp.2010.10.020_bb0110) 2009; 43 McKhann (10.1016/j.pnpbp.2010.10.020_bb0175) 1984; 34 Rosa (10.1016/j.pnpbp.2010.10.020_bb0225) 2006; 141B Lee (10.1016/j.pnpbp.2010.10.020_bb0160) 2005; 194 Jonsson (10.1016/j.pnpbp.2010.10.020_bb0145) 2006; 30 Fumagalli (10.1016/j.pnpbp.2010.10.020_bb0095) 2006; 6 Huang (10.1016/j.pnpbp.2010.10.020_bb0135) 2001; 24 Vepsalainen (10.1016/j.pnpbp.2010.10.020_bb0275) 2005; 252 Paulsen (10.1016/j.pnpbp.2010.10.020_bb0205) 2000; 54 Zhang (10.1016/j.pnpbp.2010.10.020_bb0315) 2006; 141B Laske (10.1016/j.pnpbp.2010.10.020_bb0155) 2007; 41 Moran (10.1016/j.pnpbp.2010.10.020_bb0190) 2008; 29 Yamada (10.1016/j.pnpbp.2010.10.020_bb0300) 2002; 70 Serretti (10.1016/j.pnpbp.2010.10.020_bb0240) 2007; 12 Fukumoto (10.1016/j.pnpbp.2010.10.020_bb0090) 2010; 153B Hock (10.1016/j.pnpbp.2010.10.020_bb0130) 2000; 57 Li (10.1016/j.pnpbp.2010.10.020_bb0165) 2005; 10 Ventriglia (10.1016/j.pnpbp.2010.10.020_bb0270) 2002; 7 Matsushita (10.1016/j.pnpbp.2010.10.020_bb0170) 2005; 112 Kawas (10.1016/j.pnpbp.2010.10.020_bb0150) 2003; 349 (10.1016/j.pnpbp.2010.10.020_bb0290) 1992 Miller (10.1016/j.pnpbp.2010.10.020_bb0185) 1988; 16 (10.1016/j.pnpbp.2010.10.020_bb0005) 1994 Tapia-Arancibia (10.1016/j.pnpbp.2010.10.020_bb0255) 2008; 59 Cummings (10.1016/j.pnpbp.2010.10.020_bb0050) 1994; 44 Jeste (10.1016/j.pnpbp.2010.10.020_bb0140) 2000; 8 Pezawas (10.1016/j.pnpbp.2010.10.020_bb0210) 2004; 24 Harris (10.1016/j.pnpbp.2010.10.020_bb0120) 2005; 385 Spalletta (10.1016/j.pnpbp.2010.10.020_bb0250) 2006; 13 Borroni (10.1016/j.pnpbp.2010.10.020_bb0020) 2009; 18 Tsai (10.1016/j.pnpbp.2010.10.020_bb0260) 2004; 49 Nacmias (10.1016/j.pnpbp.2010.10.020_bb0195) 2004; 367 Xu (10.1016/j.pnpbp.2010.10.020_bb0295) 2002; 111 Numata (10.1016/j.pnpbp.2010.10.020_bb0200) 2006; 401 Yasutake (10.1016/j.pnpbp.2010.10.020_bb0305) 2006; 256 Borroni (10.1016/j.pnpbp.2010.10.020_bb0015) 2006; 27 Chen (10.1016/j.pnpbp.2010.10.020_bb0040) 2004; 24 Candore (10.1016/j.pnpbp.2010.10.020_bb0035) 2006; 1089 Egan (10.1016/j.pnpbp.2010.10.020_bb0060) 2003; 112 Tsai (10.1016/j.pnpbp.2010.10.020_bb0265) 2006; 21 Frey (10.1016/j.pnpbp.2010.10.020_bb0085) 2005; 30 |
| References_xml | – volume: 50 start-page: 43 year: 2009 end-page: 48 ident: bb0220 article-title: Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants publication-title: Croat Med J contributor: fullname: Hong – volume: 38 start-page: 105 year: 2004 end-page: 111 ident: bb0235 article-title: Psychosis of Alzheimer's disease: clinical characteristics and history publication-title: J Psychiatr Res contributor: fullname: Dagerman – volume: 24 start-page: 10099 year: 2004 end-page: 10102 ident: bb0210 article-title: The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology publication-title: J Neurosci contributor: fullname: Straub – volume: 29 start-page: 1218 year: 2008 end-page: 1225 ident: bb0190 article-title: Psychosis of Alzheimer's disease: gender differences in regional perfusion publication-title: Nerobiol Aging contributor: fullname: Johnson – volume: 61 start-page: 911 year: 2007 end-page: 922 ident: bb0105 article-title: Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia publication-title: Biol Psychiatry contributor: fullname: Estivill – volume: 24 start-page: 4401 year: 2004 end-page: 4411 ident: bb0040 article-title: Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons publication-title: J Neurosci contributor: fullname: Hempstead – volume: 141B start-page: 135 year: 2006 end-page: 138 ident: bb0225 article-title: The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study publication-title: Am J Med Genet B Neuropsychiatr Genet contributor: fullname: Fananas – volume: 59 start-page: 201 year: 2008 end-page: 220 ident: bb0255 article-title: New insights into brain BDNF function in normal aging and Alzheimer disease publication-title: Brain Res Rev contributor: fullname: Arancibia – volume: 13 start-page: 176 year: 2006 end-page: 182 ident: bb0250 article-title: Delusion symptoms are associated with ApoE-4 allelic variant at the early stage of Alzheimer's disease with late onset publication-title: Eur J Neurol contributor: fullname: Caltagirone – volume: 54 start-page: S10 year: 2000 end-page: S15 ident: bb0080 article-title: Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group publication-title: Neurology contributor: fullname: Dartigues – volume: 112 start-page: 703 year: 2005 end-page: 711 ident: bb0170 article-title: Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease publication-title: J Neural Transm contributor: fullname: Masaki – volume: 367 start-page: 379 year: 2004 end-page: 383 ident: bb0195 article-title: Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease publication-title: Neurosci Lett contributor: fullname: Bracco – volume: 256 start-page: 402 year: 2006 end-page: 406 ident: bb0305 article-title: TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia publication-title: Eur Arch Psychiatry Clin Neurosci contributor: fullname: Yoneda – volume: 59 start-page: 812 year: 2006 end-page: 815 ident: bb0030 article-title: BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects publication-title: Biol Psychiatry contributor: fullname: Zubieta – volume: 30 start-page: 924 year: 2006 end-page: 933 ident: bb0145 article-title: Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study publication-title: Prog Neuropsychopharmacol Biol Psychiatry contributor: fullname: Frigessi – volume: 252 start-page: 423 year: 2005 end-page: 428 ident: bb0275 article-title: Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease publication-title: J Neurol contributor: fullname: Lehtovirta – volume: 18 start-page: 867 year: 2009 end-page: 875 ident: bb0020 article-title: BDNF genetic variations increase the risk of Alzheimer disease-related depression publication-title: J Alzheimers Dis contributor: fullname: Caimi – volume: 8 start-page: 109 year: 2003 end-page: 118 ident: bb0230 article-title: Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders publication-title: Semin Clin Neuropsychiatry contributor: fullname: Russo-Neustadt – year: 1994 ident: bb0005 article-title: Diagnostic and statistical manual of mental disorders – volume: 55 start-page: 334 year: 2006 end-page: 341 ident: bb0075 article-title: Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT and UCHL1) in Alzheimer's disease in Colombia publication-title: Neurosci Res contributor: fullname: Arboleda – volume: 12 start-page: 189 year: 1975 end-page: 198 ident: bb0070 article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician publication-title: J Psychiatr Res contributor: fullname: McHugh – volume: 12 start-page: 73 year: 2007 end-page: 92 ident: bb0240 article-title: Genetics of Alzheimer's disease. A rapidly evolving field publication-title: J Alzheimers Dis contributor: fullname: De Ronchi – volume: 7 start-page: 158 year: 2010 end-page: 164 ident: bb0025 article-title: Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease publication-title: Curr Alzheimer Res contributor: fullname: Padovani – volume: 41 start-page: 387 year: 2007 end-page: 394 ident: bb0155 article-title: BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls publication-title: J Psychiatr Res contributor: fullname: Wittorf – volume: 16 start-page: 1215 year: 1988 ident: bb0185 article-title: A simple salting out procedure for extracting DNA from human nucleated cells publication-title: Nucleic Acids Res contributor: fullname: Polesky – volume: 385 start-page: 1 year: 2005 end-page: 6 ident: bb0120 article-title: The functional COMT polymorphism, Val 158 Met, is associated with logical memory and the personality trait intellect/imagination in a cohort of healthy 79 publication-title: Neurosci Lett contributor: fullname: Deary – volume: 24 start-page: 677 year: 2001 end-page: 736 ident: bb0135 article-title: Neurotrophins: roles in neuronal development and function publication-title: Annu Rev Neurosci contributor: fullname: Reichardt – volume: 44 start-page: 2308 year: 1994 end-page: 2314 ident: bb0050 article-title: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia publication-title: Neurology contributor: fullname: Gornbein – volume: 7 start-page: 136 year: 2002 end-page: 137 ident: bb0270 article-title: Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease publication-title: Mol Psychiatry contributor: fullname: Riva – volume: 27 start-page: 1595 year: 2006 end-page: 1603 ident: bb0015 article-title: Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of publication-title: Neurobiol Aging contributor: fullname: Franzoni – volume: 70 start-page: 735 year: 2002 end-page: 744 ident: bb0300 article-title: Role for brain-derived neurotrophic factor in learning and memory publication-title: Life Sci contributor: fullname: Nabeshima – volume: 54 start-page: 1965 year: 2000 end-page: 1971 ident: bb0205 article-title: Incidence of and risk factors for hallucinations and delusions in patients with probable AD publication-title: Neurology contributor: fullname: Galasko – volume: 401 start-page: 1 year: 2006 end-page: 5 ident: bb0200 article-title: Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms publication-title: Neurosci Lett contributor: fullname: Ohta – volume: 57 start-page: 846 year: 2000 end-page: 851 ident: bb0130 article-title: Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas publication-title: Arch Neurol contributor: fullname: Otten – volume: 8 start-page: 325 year: 2004 end-page: 335 ident: bb0100 article-title: Genes and the parsing of cognitive processes publication-title: Trends Cogn Sci contributor: fullname: Weinberger – volume: 64 start-page: 7 year: 2003 end-page: 10 ident: bb0285 article-title: Neuropathologic changes in Alzheimer's disease publication-title: J Clin Psychiatry contributor: fullname: Wenk – volume: 8 start-page: 29 year: 2000 end-page: 34 ident: bb0140 article-title: Psychosis of Alzheimer's disease and related dementias: diagnostic criteria for a distinct syndrome publication-title: Am J Geriatr Psychiatry contributor: fullname: Finkel – volume: 141B start-page: 387 year: 2006 end-page: 393 ident: bb0315 article-title: Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence publication-title: Am J Med Genet B Neuropsychiatr Genet contributor: fullname: Charney – volume: 116 start-page: 266 year: 2007 end-page: 286 ident: bb0065 article-title: The role of amyloid beta peptide 42 in Alzheimer's disease publication-title: Pharmacol Ther contributor: fullname: Findeis – volume: 43 start-page: 298 year: 2009 end-page: 308 ident: bb0110 article-title: Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study publication-title: J Psychiatr Res contributor: fullname: Rainer – volume: 13 start-page: 535 year: 2010 end-page: 539 ident: bb0215 article-title: Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology publication-title: Int J Neuropsychopharmacol contributor: fullname: Nasrallah – volume: 34 start-page: 930 year: 2010 end-page: 933 ident: bb0320 article-title: The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients publication-title: Prog Neuro Psychopharmacol Biol Psychiatry contributor: fullname: Zheng – volume: 351 start-page: 56 year: 2004 end-page: 67 ident: bb0045 article-title: Alzheimer's disease publication-title: N Engl J Med contributor: fullname: Cummings – volume: 379 start-page: 229 year: 2005 end-page: 234 ident: bb0055 article-title: Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression publication-title: Neurosci Lett contributor: fullname: Kamboh – volume: 8 start-page: 5 year: 2009 end-page: 12 ident: bb0245 article-title: Subtle gene–environment interactions driving paranoia in daily life publication-title: Genes Brain Behav contributor: fullname: Krabbendam – volume: 21 start-page: 139 year: 2006 end-page: 143 ident: bb0265 article-title: The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a Chinese population publication-title: Dement Geriatr Cogn Disord contributor: fullname: Liou – volume: 6 start-page: 8 year: 2006 end-page: 15 ident: bb0095 article-title: The expanding role of BDNF: a therapeutic target for Alzheimer's disease? publication-title: Pharmacogenomics J contributor: fullname: Riva – volume: 46 start-page: 130 year: 1996 end-page: 135 ident: bb0180 article-title: The spectrum of behavioral changes in Alzheimer's disease publication-title: Neurology contributor: fullname: Gornbein – volume: 15 start-page: 260 year: 2010 end-page: 271 ident: bb0280 article-title: Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity publication-title: Mol Psychiatry contributor: fullname: Buitelaar – volume: 32 start-page: 171 year: 2007 end-page: 179 ident: bb0310 article-title: Neuropsychiatric evaluation. Apolipoprotein E e4 allele increases risk for psychotic symptoms in Alzheimer's Disease publication-title: Neuropsychopharmacology contributor: fullname: Grey – volume: 34 start-page: 939 year: 1984 end-page: 944 ident: bb0175 article-title: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease publication-title: Neurology contributor: fullname: Stadlan – year: 1992 ident: bb0290 publication-title: World Health Organization: international statistical classification of diseases and related health problems, Tenth revision 1992 (ICD-10) – volume: 30 start-page: 1501 year: 2005 end-page: 1510 ident: bb0085 article-title: Problems associated with biological markers of Alzheimer's disease publication-title: Neurochem Res contributor: fullname: Pirttila – volume: 153B start-page: 235 year: 2010 end-page: 242 ident: bb0090 article-title: Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: new data and meta-analysis publication-title: Am J Med Genet B Neuropsychiatr Genet contributor: fullname: Matsushita – volume: 387 start-page: 11 year: 2005 end-page: 16 ident: bb0010 article-title: Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese publication-title: Neurosci Lett contributor: fullname: Zhao – volume: 55 start-page: 151 year: 2007 end-page: 155 ident: bb0125 article-title: Lack of association between BDNF gene Val66Met polymorphism and Alzheimer disease in Chinese Han population publication-title: Neuropsychobiology contributor: fullname: Wu – volume: 1089 start-page: 472 year: 2006 end-page: 486 ident: bb0035 article-title: Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease publication-title: Ann NY Acad Sci contributor: fullname: Chiappelli – volume: 112 start-page: 257 year: 2003 end-page: 269 ident: bb0060 article-title: The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function publication-title: Cell contributor: fullname: Bertolino – volume: 194 start-page: 91 year: 2005 end-page: 96 ident: bb0160 article-title: Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms publication-title: Exp Neurol contributor: fullname: Vanderburg – volume: 23 start-page: 6690 year: 2003 end-page: 6694 ident: bb0115 article-title: Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance publication-title: J Neurosci contributor: fullname: Egan – volume: 349 start-page: 1056 year: 2003 end-page: 1063 ident: bb0150 article-title: Clinical practice. Early Alzheimer's disease publication-title: N Engl J Med contributor: fullname: Kawas – volume: 10 start-page: 809 year: 2005 end-page: 810 ident: bb0165 article-title: The BDNF Val66Met polymorphism is not associated with late onset Alzheimer's disease in three case-control samples publication-title: Mol Psychiatry contributor: fullname: Hardy – volume: 49 start-page: 10 year: 2004 end-page: 12 ident: bb0260 article-title: Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset publication-title: Neuropsychobiology contributor: fullname: Lin – volume: 111 start-page: 573 year: 2002 end-page: 574 ident: bb0295 article-title: Positive results in association studies are associated with departure from Hardy Weinberg equilibrium: hint for genotyping error? publication-title: Hum Genet contributor: fullname: Meyers – volume: 367 start-page: 379 year: 2004 ident: 10.1016/j.pnpbp.2010.10.020_bb0195 article-title: Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease publication-title: Neurosci Lett doi: 10.1016/j.neulet.2004.06.039 contributor: fullname: Nacmias – volume: 34 start-page: 930 year: 2010 ident: 10.1016/j.pnpbp.2010.10.020_bb0320 article-title: The study of BDNF Val66Met polymorphism in Chinese schizophrenic patients publication-title: Prog Neuro Psychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2010.04.019 contributor: fullname: Zhou – volume: 59 start-page: 201 year: 2008 ident: 10.1016/j.pnpbp.2010.10.020_bb0255 article-title: New insights into brain BDNF function in normal aging and Alzheimer disease publication-title: Brain Res Rev doi: 10.1016/j.brainresrev.2008.07.007 contributor: fullname: Tapia-Arancibia – volume: 401 start-page: 1 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0200 article-title: Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms publication-title: Neurosci Lett doi: 10.1016/j.neulet.2006.02.054 contributor: fullname: Numata – volume: 112 start-page: 703 year: 2005 ident: 10.1016/j.pnpbp.2010.10.020_bb0170 article-title: Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease publication-title: J Neural Transm doi: 10.1007/s00702-004-0210-3 contributor: fullname: Matsushita – volume: 385 start-page: 1 year: 2005 ident: 10.1016/j.pnpbp.2010.10.020_bb0120 article-title: The functional COMT polymorphism, Val 158 Met, is associated with logical memory and the personality trait intellect/imagination in a cohort of healthy 79year olds publication-title: Neurosci Lett doi: 10.1016/j.neulet.2005.04.104 contributor: fullname: Harris – volume: 15 start-page: 260 year: 2010 ident: 10.1016/j.pnpbp.2010.10.020_bb0280 article-title: Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity publication-title: Mol Psychiatry doi: 10.1038/mp.2008.109 contributor: fullname: Verhagen – volume: 24 start-page: 4401 year: 2004 ident: 10.1016/j.pnpbp.2010.10.020_bb0040 article-title: Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0348-04.2004 contributor: fullname: Chen – volume: 24 start-page: 10099 year: 2004 ident: 10.1016/j.pnpbp.2010.10.020_bb0210 article-title: The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2680-04.2004 contributor: fullname: Pezawas – volume: 153B start-page: 235 year: 2010 ident: 10.1016/j.pnpbp.2010.10.020_bb0090 article-title: Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: new data and meta-analysis publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.30986 contributor: fullname: Fukumoto – volume: 6 start-page: 8 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0095 article-title: The expanding role of BDNF: a therapeutic target for Alzheimer's disease? publication-title: Pharmacogenomics J doi: 10.1038/sj.tpj.6500337 contributor: fullname: Fumagalli – volume: 8 start-page: 29 year: 2000 ident: 10.1016/j.pnpbp.2010.10.020_bb0140 article-title: Psychosis of Alzheimer's disease and related dementias: diagnostic criteria for a distinct syndrome publication-title: Am J Geriatr Psychiatry doi: 10.1097/00019442-200002000-00004 contributor: fullname: Jeste – volume: 8 start-page: 325 year: 2004 ident: 10.1016/j.pnpbp.2010.10.020_bb0100 article-title: Genes and the parsing of cognitive processes publication-title: Trends Cogn Sci doi: 10.1016/j.tics.2004.05.011 contributor: fullname: Goldberg – volume: 54 start-page: 1965 year: 2000 ident: 10.1016/j.pnpbp.2010.10.020_bb0205 article-title: Incidence of and risk factors for hallucinations and delusions in patients with probable AD publication-title: Neurology doi: 10.1212/WNL.54.10.1965 contributor: fullname: Paulsen – volume: 70 start-page: 735 year: 2002 ident: 10.1016/j.pnpbp.2010.10.020_bb0300 article-title: Role for brain-derived neurotrophic factor in learning and memory publication-title: Life Sci doi: 10.1016/S0024-3205(01)01461-8 contributor: fullname: Yamada – volume: 379 start-page: 229 year: 2005 ident: 10.1016/j.pnpbp.2010.10.020_bb0055 article-title: Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression publication-title: Neurosci Lett doi: 10.1016/j.neulet.2005.01.008 contributor: fullname: Desai – volume: 111 start-page: 573 year: 2002 ident: 10.1016/j.pnpbp.2010.10.020_bb0295 article-title: Positive results in association studies are associated with departure from Hardy Weinberg equilibrium: hint for genotyping error? publication-title: Hum Genet doi: 10.1007/s00439-002-0819-y contributor: fullname: Xu – volume: 351 start-page: 56 year: 2004 ident: 10.1016/j.pnpbp.2010.10.020_bb0045 article-title: Alzheimer's disease publication-title: N Engl J Med doi: 10.1056/NEJMra040223 contributor: fullname: Cummings – volume: 18 start-page: 867 year: 2009 ident: 10.1016/j.pnpbp.2010.10.020_bb0020 article-title: BDNF genetic variations increase the risk of Alzheimer disease-related depression publication-title: J Alzheimers Dis doi: 10.3233/JAD-2009-1191 contributor: fullname: Borroni – volume: 12 start-page: 189 year: 1975 ident: 10.1016/j.pnpbp.2010.10.020_bb0070 article-title: “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician publication-title: J Psychiatr Res doi: 10.1016/0022-3956(75)90026-6 contributor: fullname: Folstein – volume: 43 start-page: 298 year: 2009 ident: 10.1016/j.pnpbp.2010.10.020_bb0110 article-title: Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study publication-title: J Psychiatr Res doi: 10.1016/j.jpsychires.2008.05.008 contributor: fullname: Grunblatt – volume: 141B start-page: 387 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0315 article-title: Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.30332 contributor: fullname: Zhang – volume: 24 start-page: 677 year: 2001 ident: 10.1016/j.pnpbp.2010.10.020_bb0135 article-title: Neurotrophins: roles in neuronal development and function publication-title: Annu Rev Neurosci doi: 10.1146/annurev.neuro.24.1.677 contributor: fullname: Huang – volume: 194 start-page: 91 year: 2005 ident: 10.1016/j.pnpbp.2010.10.020_bb0160 article-title: Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms publication-title: Exp Neurol doi: 10.1016/j.expneurol.2005.01.026 contributor: fullname: Lee – volume: 55 start-page: 151 year: 2007 ident: 10.1016/j.pnpbp.2010.10.020_bb0125 article-title: Lack of association between BDNF gene Val66Met polymorphism and Alzheimer disease in Chinese Han population publication-title: Neuropsychobiology doi: 10.1159/000106473 contributor: fullname: He – volume: 32 start-page: 171 year: 2007 ident: 10.1016/j.pnpbp.2010.10.020_bb0310 article-title: Neuropsychiatric evaluation. Apolipoprotein E e4 allele increases risk for psychotic symptoms in Alzheimer's Disease publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301148 contributor: fullname: Zdanys – volume: 10 start-page: 809 year: 2005 ident: 10.1016/j.pnpbp.2010.10.020_bb0165 article-title: The BDNF Val66Met polymorphism is not associated with late onset Alzheimer's disease in three case-control samples publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001702 contributor: fullname: Li – volume: 8 start-page: 5 year: 2009 ident: 10.1016/j.pnpbp.2010.10.020_bb0245 article-title: Subtle gene–environment interactions driving paranoia in daily life publication-title: Genes Brain Behav doi: 10.1111/j.1601-183X.2008.00434.x contributor: fullname: Simons – volume: 49 start-page: 10 year: 2004 ident: 10.1016/j.pnpbp.2010.10.020_bb0260 article-title: Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset publication-title: Neuropsychobiology doi: 10.1159/000075332 contributor: fullname: Tsai – volume: 64 start-page: 7 issue: Suppl 9 year: 2003 ident: 10.1016/j.pnpbp.2010.10.020_bb0285 article-title: Neuropathologic changes in Alzheimer's disease publication-title: J Clin Psychiatry contributor: fullname: Wenk – volume: 44 start-page: 2308 year: 1994 ident: 10.1016/j.pnpbp.2010.10.020_bb0050 article-title: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia publication-title: Neurology doi: 10.1212/WNL.44.12.2308 contributor: fullname: Cummings – volume: 55 start-page: 334 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0075 article-title: Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT and UCHL1) in Alzheimer's disease in Colombia publication-title: Neurosci Res doi: 10.1016/j.neures.2006.04.006 contributor: fullname: Forero – volume: 349 start-page: 1056 year: 2003 ident: 10.1016/j.pnpbp.2010.10.020_bb0150 article-title: Clinical practice. Early Alzheimer's disease publication-title: N Engl J Med doi: 10.1056/NEJMcp022295 contributor: fullname: Kawas – volume: 116 start-page: 266 year: 2007 ident: 10.1016/j.pnpbp.2010.10.020_bb0065 article-title: The role of amyloid beta peptide 42 in Alzheimer's disease publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2007.06.006 contributor: fullname: Findeis – volume: 61 start-page: 911 year: 2007 ident: 10.1016/j.pnpbp.2010.10.020_bb0105 article-title: Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2006.08.025 contributor: fullname: Gratacos – volume: 46 start-page: 130 year: 1996 ident: 10.1016/j.pnpbp.2010.10.020_bb0180 article-title: The spectrum of behavioral changes in Alzheimer's disease publication-title: Neurology doi: 10.1212/WNL.46.1.130 contributor: fullname: Mega – volume: 16 start-page: 1215 year: 1988 ident: 10.1016/j.pnpbp.2010.10.020_bb0185 article-title: A simple salting out procedure for extracting DNA from human nucleated cells publication-title: Nucleic Acids Res doi: 10.1093/nar/16.3.1215 contributor: fullname: Miller – volume: 8 start-page: 109 year: 2003 ident: 10.1016/j.pnpbp.2010.10.020_bb0230 article-title: Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders publication-title: Semin Clin Neuropsychiatry doi: 10.1053/scnp.2003.50014 contributor: fullname: Russo-Neustadt – volume: 23 start-page: 6690 year: 2003 ident: 10.1016/j.pnpbp.2010.10.020_bb0115 article-title: Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance publication-title: J Neurosci doi: 10.1523/JNEUROSCI.23-17-06690.2003 contributor: fullname: Hariri – volume: 387 start-page: 11 year: 2005 ident: 10.1016/j.pnpbp.2010.10.020_bb0010 article-title: Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese publication-title: Neurosci Lett doi: 10.1016/j.neulet.2005.07.009 contributor: fullname: Bian – volume: 112 start-page: 257 year: 2003 ident: 10.1016/j.pnpbp.2010.10.020_bb0060 article-title: The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function publication-title: Cell doi: 10.1016/S0092-8674(03)00035-7 contributor: fullname: Egan – year: 1992 ident: 10.1016/j.pnpbp.2010.10.020_bb0290 – volume: 29 start-page: 1218 year: 2008 ident: 10.1016/j.pnpbp.2010.10.020_bb0190 article-title: Psychosis of Alzheimer's disease: gender differences in regional perfusion publication-title: Nerobiol Aging doi: 10.1016/j.neurobiolaging.2007.02.024 contributor: fullname: Moran – volume: 30 start-page: 924 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0145 article-title: Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study publication-title: Prog Neuropsychopharmacol Biol Psychiatry doi: 10.1016/j.pnpbp.2006.02.008 contributor: fullname: Jonsson – volume: 141B start-page: 135 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0225 article-title: The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.30266 contributor: fullname: Rosa – volume: 59 start-page: 812 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0030 article-title: BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2005.09.022 contributor: fullname: Bueller – volume: 57 start-page: 846 year: 2000 ident: 10.1016/j.pnpbp.2010.10.020_bb0130 article-title: Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas publication-title: Arch Neurol doi: 10.1001/archneur.57.6.846 contributor: fullname: Hock – volume: 41 start-page: 387 year: 2007 ident: 10.1016/j.pnpbp.2010.10.020_bb0155 article-title: BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls publication-title: J Psychiatr Res doi: 10.1016/j.jpsychires.2006.01.014 contributor: fullname: Laske – volume: 38 start-page: 105 year: 2004 ident: 10.1016/j.pnpbp.2010.10.020_bb0235 article-title: Psychosis of Alzheimer's disease: clinical characteristics and history publication-title: J Psychiatr Res doi: 10.1016/S0022-3956(03)00092-X contributor: fullname: Schneider – volume: 13 start-page: 535 year: 2010 ident: 10.1016/j.pnpbp.2010.10.020_bb0215 article-title: Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology publication-title: Int J Neuropsychopharmacol doi: 10.1017/S1461145709991015 contributor: fullname: Pillai – year: 1994 ident: 10.1016/j.pnpbp.2010.10.020_bb0005 – volume: 50 start-page: 43 year: 2009 ident: 10.1016/j.pnpbp.2010.10.020_bb0220 article-title: Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants publication-title: Croat Med J doi: 10.3325/cmj.2009.50.43 contributor: fullname: Pivac – volume: 1089 start-page: 472 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0035 article-title: Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease publication-title: Ann NY Acad Sci doi: 10.1196/annals.1386.008 contributor: fullname: Candore – volume: 27 start-page: 1595 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0015 article-title: Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2005.09.029 contributor: fullname: Borroni – volume: 7 start-page: 136 year: 2002 ident: 10.1016/j.pnpbp.2010.10.020_bb0270 article-title: Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4000952 contributor: fullname: Ventriglia – volume: 21 start-page: 139 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0265 article-title: The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a Chinese population publication-title: Dement Geriatr Cogn Disord doi: 10.1159/000090673 contributor: fullname: Tsai – volume: 13 start-page: 176 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0250 article-title: Delusion symptoms are associated with ApoE-4 allelic variant at the early stage of Alzheimer's disease with late onset publication-title: Eur J Neurol doi: 10.1111/j.1468-1331.2006.01165.x contributor: fullname: Spalletta – volume: 34 start-page: 939 year: 1984 ident: 10.1016/j.pnpbp.2010.10.020_bb0175 article-title: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease publication-title: Neurology doi: 10.1212/WNL.34.7.939 contributor: fullname: McKhann – volume: 12 start-page: 73 year: 2007 ident: 10.1016/j.pnpbp.2010.10.020_bb0240 article-title: Genetics of Alzheimer's disease. A rapidly evolving field publication-title: J Alzheimers Dis doi: 10.3233/JAD-2007-12108 contributor: fullname: Serretti – volume: 7 start-page: 158 year: 2010 ident: 10.1016/j.pnpbp.2010.10.020_bb0025 article-title: Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease publication-title: Curr Alzheimer Res doi: 10.2174/156720510790691173 contributor: fullname: Borroni – volume: 30 start-page: 1501 year: 2005 ident: 10.1016/j.pnpbp.2010.10.020_bb0085 article-title: Problems associated with biological markers of Alzheimer's disease publication-title: Neurochem Res doi: 10.1007/s11064-005-8827-7 contributor: fullname: Frey – volume: 256 start-page: 402 year: 2006 ident: 10.1016/j.pnpbp.2010.10.020_bb0305 article-title: TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia publication-title: Eur Arch Psychiatry Clin Neurosci doi: 10.1007/s00406-006-0652-8 contributor: fullname: Yasutake – volume: 252 start-page: 423 year: 2005 ident: 10.1016/j.pnpbp.2010.10.020_bb0275 article-title: Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease publication-title: J Neurol doi: 10.1007/s00415-005-0667-5 contributor: fullname: Vepsalainen – volume: 54 start-page: S10 year: 2000 ident: 10.1016/j.pnpbp.2010.10.020_bb0080 article-title: Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group publication-title: Neurology contributor: fullname: Fratiglioni |
| SSID | ssj0001303 |
| Score | 2.1893673 |
| Snippet | Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative disorder with a high prevalence. Since behavioral disturbances, such as psychotic... OBJECTIVEAlzheimer's disease (AD) is an irreversible, progressive neurodegenerative disorder with a high prevalence. Since behavioral disturbances, such as... |
| SourceID | proquest crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 356 |
| SubjectTerms | Age Factors Alzheimer Disease - epidemiology Alzheimer Disease - genetics Alzheimer Disease - physiopathology Alzheimer Disease - psychology Alzheimer's disease Amino Acid Substitution Brain derived neurotrophic factor Val66Met Brain-Derived Neurotrophic Factor - genetics Brain-Derived Neurotrophic Factor - physiology Croatia Disease Progression Female Gene Frequency Genetic Predisposition to Disease Genotype Humans Male Male and female subjects Onset of disease Polymorphism, Single Nucleotide Psychotic Disorders - genetics Psychotic Disorders - physiopathology Psychotic symptoms Schizophrenia - genetics Schizophrenia - physiopathology Sex Factors Time Factors |
| Title | Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease |
| URI | https://dx.doi.org/10.1016/j.pnpbp.2010.10.020 https://www.ncbi.nlm.nih.gov/pubmed/21044653 https://search.proquest.com/docview/859054333 https://search.proquest.com/docview/862785110 |
| Volume | 35 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb5tAEF45yaWXqu-6L-2hSg8xlYEFw9Ft3aaValmKW-WGYNlVcByMAo6U_vrO7AOwokRtpV6QteKxMJ9nv9l5EfI2inNXBkI6IZexw4TMnBQTgUEvsph7WLQIPbrHJ5P5afRpxmaDgW1L2o39V0nDGMgaM2f_QtrtTWEAfoPM4QhSh-Mfyf0D9nw4yuFRV-jZx9obzeWmOiu46a1z9DNdh-F30WCDBrD84UPbRhkmJQtOra8vqmZzoYJlp-tfZ6JQXVYm9Y5Hx5DaBcZ4ocaEk9UDHX2jqiuLreNydMUnBYvdKGulnIurVLVbn4t1u1bMi3OwvbnOKgI8dnvXeaFGv4DxnJZphxtgu1VhLlil_U0NV0V1Gf-M2mmz2TY7waDoJHWQMOm1SyvsCMaYp_M1rUbXBVAMcr2eevaDsLfS-3oduLGI6P2M1fuqrLJKR_9hAKA37tbMNpLxBCeFc0I_CWYR75EDD3QeqNyD6dfZ6beWFiBZUBt-5iVsCSwVbHjjUbfRpNvMIEWHlg_IfWPH0KkG4EMyEOUjcrjQEr8e0WWX11eP6CFd9LDwmAiFUmpQSvsopRql1KKU9lFKAaW0RSm1KKVwrxal72pqMPqE_Pg8W348dkzDD4f7E7dx4mwcy8DNYMkFO8GLIsbyQOax5G4WRmmWR1hOT8pQxAFjngS6irWXBA8k0N4w95-S_XJTiueESg5CQDKb5cj4J5lkjEm8lMWM-96QjOz3TSpd1yWxAY-rRIkjQXHgIIhjSEIrg8RQU005EwDN3RdSK7EEFDd649JSbLZ1EgUxmEu-799xSojgAoI-JM-0sNu5eu5YlUZ88a8Te0nudX-8V2S_udyK12SvzrdvDHJ_A8n71mU |
| link.rule.ids | 315,782,786,27933,27934 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Brain+derived+neurotrophic+factor+Val66Met+polymorphism+and+psychotic+symptoms+in+Alzheimer%27s+disease&rft.jtitle=Progress+in+neuro-psychopharmacology+%26+biological+psychiatry&rft.au=Pivac%2C+Nela&rft.au=Nikolac%2C+Matea&rft.au=Nedic%2C+Gordana&rft.au=Mustapic%2C+Maja&rft.date=2011-03-30&rft.pub=Elsevier+Inc&rft.issn=0278-5846&rft.eissn=1878-4216&rft.volume=35&rft.issue=2&rft.spage=356&rft.epage=362&rft_id=info:doi/10.1016%2Fj.pnpbp.2010.10.020&rft.externalDocID=S0278584610004069 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0278-5846&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0278-5846&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0278-5846&client=summon |